These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3732336)

  • 21. The dexamethasone suppression test in depression.
    Dam H; Mellerup ET; Rafaelsen OJ
    J Affect Disord; 1985; 8(1):95-103. PubMed ID: 3156917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial dexamethasone suppression tests in psychiatric illness: Part III. The influence of intervening variables.
    Baumgartner A; Haack D; Vecsei P
    Psychiatry Res; 1986 May; 18(1):45-64. PubMed ID: 3737787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone suppression test as a predictor of drug treatment response.
    Arató M; Rihmer Z; Szádóczky E; Grof P
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):649-52. PubMed ID: 6152343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
    Timmerman L; de Beurs P; Tan BK; Leijnse-Ybema H; Sanchez C; Høpfner Petersen HE; Cohen Stuart MH
    Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors interfering with the 1 mg dexamethasone suppression test in depression.
    Barocka A; Pichl J; Beck G; Rupprecht R
    Pharmacopsychiatry; 1987 Nov; 20(6):258-61. PubMed ID: 3432360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Informed use of the dexamethasone suppression test.
    Carroll BJ
    J Clin Psychiatry; 1986 Jan; 47(1 Suppl):10-2. PubMed ID: 3941065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressive attributional style and the dexamethasone suppression test: relationship to the endogenous/melancholic distinction and to each other.
    Peselow ED; Fieve RR
    Psychopathology; 1992; 25(4):173-82. PubMed ID: 1492140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J; Linka M; Matkowski K; Kanarkowski R
    Psychiatr Pol; 1991; 25(5):9-15. PubMed ID: 1821997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders.
    Zhou DF; Shen YC; Shu LN; Lo HC
    Biol Psychiatry; 1987 Jul; 22(7):883-91. PubMed ID: 3607115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamethasone suppression test in depression and other psychiatric illness.
    Coppen A; Abou-Saleh M; Milln P; Metcalfe M; Harwood J; Bailey J
    Br J Psychiatry; 1983 May; 142():498-504. PubMed ID: 6409195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial dexamethasone tests for predicting relapse in depressive disorder.
    Targum SD
    South Med J; 1984 Nov; 77(11):1402-5. PubMed ID: 6494962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical investigations into antidepressive mechanisms. II. Dexamethasone suppression test predicts response to nomifensine or amitriptyline.
    Beckmann H; Holzmüller B; Fleckenstein P
    Acta Psychiatr Scand; 1984 Oct; 70(4):342-53. PubMed ID: 6388249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders.
    Sora I; Nishimon K; Otsuki S
    Biol Psychiatry; 1986 Jun; 21(7):621-31. PubMed ID: 3708036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical diagnostic value of dexamethasone suppression test in depressive illness.
    Hwu HG; Chen TY; Yang YY
    Ann Acad Med Singap; 1985 Jan; 14(1):104-9. PubMed ID: 4004115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dexamethasone suppression test in psychiatry.
    Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA
    N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.
    Mauri MC; Vita A; Giobbio GM; Ferrara A; Dieci M; Bitetto A; Altamura AC
    Int Clin Psychopharmacol; 1994; 9(1):3-7. PubMed ID: 8195579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The predictive value of the dexamethasone suppression test. A placebo-controlled study.
    Peselow ED; Stanley M; Filippi AM; Barouche F; Goodnick P; Fieve RR
    Br J Psychiatry; 1989 Nov; 155():667-72. PubMed ID: 2532946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid normalization of the dexamethasone suppression test with mianserin.
    King DJ; Devaney NM; Cooper SJ
    Int Clin Psychopharmacol; 1987 Apr; 2(2):111-6. PubMed ID: 3598168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.